Dr. Antonio Calles 馃珌馃毉路 @Tony_Calles 路 X路路 14 hours agoScore70
Body
馃摉 A new chapter in SCLC therapy has been written by @sands_jacob
馃挜 DeLLphi-305 sets a new standard of care in maintenance after induction chemo-io for patients with ES-SCLC
#ESMO26 @myESMO
179 views 路 11 likes 路 2 reposts 路 0 replies
Conference abstracts
LBA3matched by Presidential Symposium I
Tarlatamab plus durvalumab (durva) vs durva as 1L maintenance (1LM) therapy following durva, platinum, and etoposide (1L durva + EP) in extensive-stage small cell lung cancer (ES-SCLC): Primary analysis of the phase 3 DeLLphi-305 trial
https://esmocongress.esmo.orgSource: Dr. Antonio Calles 馃珌馃毉 路 x.com